Skip to content

Clinical trials

Completed Phase 3 trials in Oman

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Completed Country / region: Oman Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20113
20131
20162
20182
20201
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Pfizer4
Arrowhead Pharmaceuticals1
Hoffmann-La Roche1
Mast Therapeutics, Inc.1
Novartis1
Octapharma1
mAbxience Research S.L.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell3
Hemophilia A2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Vaso-Occlusive Crises2
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Chronic Urticaria1
Hematologic Diseases1
Hemophilia B1
Hemorrhage1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.